Aligos Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH).
ALGS Key Statistics
Stock Snapshot
The current Aligos Therapeutics(ALGS) stock price is $6.44, with a market capitalization of 40.28M. The stock trades at a price-to-earnings (P/E) ratio of -0.75.
On 2026-05-05, Aligos Therapeutics(ALGS) stock traded between a low of $6.44 and a high of $6.44. Shares are currently priced at $6.44, which is 0.0% above the low and 0.0% below the high.
The Aligos Therapeutics(ALGS)'s current trading volume is 945, compared to an average daily volume of 165.07K.
In the last year, Aligos Therapeutics(ALGS) shares hit a 52-week high of $13.69 and a 52-week low of $4.20.
In the last year, Aligos Therapeutics(ALGS) shares hit a 52-week high of $13.69 and a 52-week low of $4.20.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.